期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

腹腔化疗的临床应用 被引量：3

下载PDF
导出
摘要 腹腔化疗是一种高选择性区域药物治疗的方法,在胃肠恶性肿瘤的姑息治疗和防止术后肿瘤复发转移方面具有重要意义。腹腔化疗较静脉化疗具有明显的药代动力学优势。在肿瘤的综合治疗中发挥着重要的作用。
作者 张博
机构地区 武警北京总队第三医院外三科
出处 《现代肿瘤医学》 CAS 2008年第7期1248-1250,共3页 Journal of Modern Oncology
关键词 腹腔化疗 胃肠道恶性肿瘤 临床应用
分类号 R730.53 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure [ J ]. J Natl Cancer Inst, 1997, 89(7) :480 -487.
  • 2冯国光,郁宝铭,周锡庚.腹腔化疗在防治胃肠道癌术后复发中的应用[J].中国实用外科杂志,1995,15(12):720-721. 被引量：65
  • 3Speryer JL. The rationale behind intrapefitoneal chemotherapy in gastrointestinal malignancies[J]. Semin Oncol, 1985,12:23.
  • 4Meyer HJ, Zachert HR, Opitz GJ, et al. Muhimodality therapy concepts in stomach carcinoma[ J]. Kongressbd Dtsch Ges Chir Kongr, 2001, 118:51 -57.
  • 5Schwarz RE, Zagala Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy [J]. Ann Surg Oncol, 2002, 9 (4) :394 -400.
  • 6Maruyama M, Nagahama T, Ebuchi M, et al. Experimental study on intraperitoneal versus in travenous CPT - 11 for peritoneal seeding and liver metastasis [ J ]. Gan To Kagaku Ryoho, 2000, 27 (12) : 1855 - 1857.
  • 7Nomura E, Ni ki M, Fu jii K , et al . Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer [J] . Gastric Cancer , 2001 , 4 (2) :75 -82.
  • 8Yu W, Whang I, Chung H Y,et al. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: resuits of a prospective randomized trial [J]. World J Surg, 2001 , 25(8) :985 -990.
  • 9Jeung H C, Rha S Y, Jang W l, et al. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy [ J] . Br J Surg, 2002, 89 (4) :460 -466.
  • 10Kitani K , Morimoto T , Shibata N , et al. Effects of intraperitoneal injection of low - dose CDDP on 3 patients with ascites owing to peritonitis carcinoma at osa of gastric and colorectal carcinoma [J] . Gan To Kagaku Ryoho , 2001, 28(11) :1666 -1668.

共引文献64

同被引文献24

  • 1王锋,汪年松.香菇多糖对淋巴细胞脱氧核糖核酸蛋白体转录活性的影响[J].中国基层医药,2005,12(10):1313-1314. 被引量：6
  • 2刘伟,李苏宜.卵巢癌化疗新进展[J].肿瘤基础与临床,2006,19(6):526-528. 被引量：19
  • 3Jemal A,Siegel R,Ward E,et al.Cancer statistics,2006[J].CA Cancer J Clin,2006,56(2):106-130.
  • 4Ozols RF.Challenges for chemotherapy in ovarian cancer[J].Ann Oncol,2006,17(Suppl 5):v181-187.
  • 5Anselmo-Murphy AM.Challenges of IP chemotherapy for ovarian cancer[J].Oncology (Williston Park),2009,23(11 Suppl Nurse Ed):21-22.
  • 6Nicoletto MO,Dalla PM,Donach ME,et al.Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer[J].Tumori,2010,96(6):918-925.
  • 7Jaaback K,Johnson N.Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer[J].Cochrane Database Syst Rev,2006,1:CD005340.
  • 8Hamilton CA,Berek JS.Intraperitoneal chemotherapy for ovarian cancer[J].Curr Opin Oncol,2006,18(5):507-515.
  • 9Weinberg LE,Rodriguez G, I-lurteau JA. The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer. J Surg Oncol, 2010,101 (4) : 334-343.
  • 10Pant AC,Diaz-Montes T,Tanner E,et al. Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer. J Chemother,2010,22(4) :270-274.

引证文献3

二级引证文献26

现代肿瘤医学
2008年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部